Not Yet Recruiting
A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors - CA076-001
Updated:
23 December, 2022
|
ClinicalTrials.gov
Phase
Gender(s)
Age Range
Location(s)
Not Yet Recruiting
Inclusion Criteria: - Males ≥ 18 years of age - Has histological or cytological confirmation of advanced solid tumors including those who have progressed on standard anticancer therapy or for whom no other approved conventional therapy exists - Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 1 Exclusion Criteria: - Persistent diarrhea National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Grade ≥ 2 - History of concurrent second cancers requiring active and ongoing systemic treatment Other protocol-defined inclusion/exclusion criteria apply
If you want to report a side effect, you can report directly to the Danish Medicines Agency via the website www.meldenbivirkning.dk
We recommend that you also contact BMS to report side effects.
Side effects and other reportable events are defined here
Report side effects or product quality complaints: Medical Information
466-DK-2200001